Moxifloxacin-based strategies for first-line treatment of Helicobacter pylori infection.
Nista EC, Candelli M, Zocco MA, Cazzato IA, Cremonini F, Ojetti V, Santoro M, Finizio R, Pignataro G, Cammarota G, Gasbarrini G, Gasbarrini A.
Nista EC, et al. Among authors: cammarota g.
Aliment Pharmacol Ther. 2005 May 15;21(10):1241-7. doi: 10.1111/j.1365-2036.2005.02412.x.
Aliment Pharmacol Ther. 2005.
PMID: 15882245
Free article.
Clinical Trial.